ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP) Stock Price, Quote, News & History

Key Statistics

Open

$0.30

$0.31

Volume / Avg.

5.89M / 571.89K

Day Range

$0.27 - $0.32

52 Wk Range

0.33 - 0.74

Market Cap

P/E Ratio

11.95

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

3.73

Recent Elite Pharmaceuticals Inc News

Earnings Scheduled For June 14, 2019

Lisa Levin

Elite Pharmaceuticals Reports Q4 2026 Results: Full Earnings Call Transcript

Elite Pharmaceuticals (OTC:ELTP) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive

Benzinga Insights

PRO
Elite Pharmaceuticals Q4 EPS $0.01 Down From $0.02 YoY, Sales $40.748M Up From $31.996M YoY

Elite Pharmaceuticals (OTC:ELTP) reported quarterly earnings of $0.01 per share. This is a 50 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $40.748 million in

Benzinga Newsdesk

PRO
Elite Pharmaceuticals Q3 EPS $0.01 Up From $(0.01) YoY, Sales $31.589M Up From $14.364M YoY

Elite Pharmaceuticals (OTC:ELTP) reported quarterly earnings of $0.01 per share. This is a 200 percent increase over losses of $(0.01) per share from the same period last year. The company reported $31.589 million in

Benzinga Newsdesk

PRO
Elite Pharmaceuticals Q1 EPS $(0.01), Sales $40.211M Up From $18.803M YoY

Elite Pharmaceuticals (OTC:ELTP) reported quarterly losses of $(0.01) per share. The company reported $40.211 million in sales this quarter. This is a 113.85 percent increase over sales of $18.803 million the same

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

19.04M

Investing Cash Flow (TTM)

-1.52M

Financing Cash Flow (TTM)

-306.22K

Free Cash Flow (TTM)

17.53M

Capital Expenditure (TTM)

-1.52M

Net Change in Cash (TTM)

17.22M

Valuation Metrics

Enterprise Value

$300.53M

PE Ratio (TTM)

11.95

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.74

PB Ratio (TTM)

3.91

Earnings Yield % (TTM)

8.37%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

6.11

Price / EBITDA (TTM)

6.89

Price / Free Cash Flow (TTM)

17.88

Book Value / Share

$0.09

Company Debt

Total Debt

$3.01M

LT Debt

$2.78M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$629.01K

Total Cash

$38.94M

Debt to Equity

0.05

Issuance of Debt (TTM)

-$629.01K

Repayment of Debt (TTM)

-$629.01K

Key Statistics

Open

$0.30

$0.31

Volume / Avg.

5.89M / 571.89K

Day Range

$0.27 - $0.32

52 Wk Range

0.33 - 0.74

Market Cap

P/E Ratio

11.95

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

3.73

About

Sector

Health Care

Industry

Pharmaceuticals

Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's single operating segment is Abbreviated...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

ELTP

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

ELTP

FAQ

How do I buy ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP) stock?

You can purchase shares of ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (OTCQB:ELTP) through any online brokerage.

View our list of the best stock brokerages

Who are ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP) competitors?

There are no as such competitors for ELITE PHARMS INC by Elite Pharmaceuticals, Inc..

What is the forecast, or price target, for ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP) stock?

There is no analysis for ELITE PHARMS INC by Elite Pharmaceuticals, Inc. to provide a consensus price target.

What is the current price for ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP)?

The stock price for ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (OTCQB: ELTP) is $0.31 last updated August 14, 2026 at 3:59 PM EDT.

Does ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP) pay a dividend?

There are no upcoming dividends for ELITE PHARMS INC by Elite Pharmaceuticals, Inc..

When is ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (OTCQB:ELTP) reporting earnings?

ELITE PHARMS INC by Elite Pharmaceuticals, Inc. does not have any upcoming earnings scheduled.

Is ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP) going to split?

There is no upcoming split for ELITE PHARMS INC by Elite Pharmaceuticals, Inc..

What sector and industry does ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP) operate in?

ELITE PHARMS INC by Elite Pharmaceuticals, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Benzinga

Benzinga